Schroeder Thilo
- SEC CIK
- 0001776412
No open-market purchases or sales filed in the past year.
Current role at each company
- RVMD Revolution Medicines, Inc.Directoras of Dec 9, 2024
- PMVP PMV Pharmaceuticals, Inc.Directoras of Oct 8, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schroeder Thilo as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RVMD Revolution Medicines, Inc.
Director9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2024 (view filing) | Dec 5 | 4 days | Schroeder ThiloDirector | PPurchase | +1.30M | $46.00 | +$60.0M | New position760.9K after | 2 lots |
| Mar 10, 2023 (view filing) | Mar 7-10 | 3 daysLate | Schroeder ThiloDirector | PPurchase | +650.0K | $21.76 | +$14.1M | +72.0%1.55M after | 4 lots |
| Jul 26, 2022 (view filing) | Jul 22 | 4 days | Schroeder ThiloDirector | PPurchase | +250.0K | $20.00 | +$5.00M | +25.7%1.22M after | |
| Mar 29, 2022 (view filing) | Mar 25-28 | 4 days | Schroeder ThiloDirector | PPurchase | +42.7K | $24.79 | +$1.06M | +4.6%971.3K after | 3 lots |
| Mar 24, 2022 (view filing) | Mar 22-24 | 2 days | Schroeder ThiloDirector | PPurchase | +232.4K | $23.63 | +$5.49M | +33.4%928.6K after | 6 lots |
| Mar 21, 2022 (view filing) | Mar 17-21 | 4 days | Schroeder ThiloDirector | PPurchase | +168.1K | $20.40 | +$3.43M | +31.8%696.2K after | 5 lots |
| Mar 14, 2022 (view filing) | Mar 10-11 | 4 days | Schroeder ThiloDirector | PPurchase | +43.5K | $20.63 | +$897.8K | +9.0%528.2K after | 3 lots |
| Mar 9, 2022 (view filing) | Mar 7-9 | 2 days | Schroeder ThiloDirector | PPurchase | +246.4K | $18.91 | +$4.66M | +103.4%484.7K after | 6 lots |
| Mar 4, 2022 (view filing) | Feb 18, 2020-Mar 4, 2022 | 745 daysLate | Schroeder ThiloDirector | PPurchase | +1.09M | $26.30 | +$28.6M | New position238.2K after | 7 lots |
PMVP PMV Pharmaceuticals, Inc.
Director17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2021 (view filing) | Oct 6 | 2 days | Schroeder ThiloDirector | SSale | −800 | $30.15 | −$24.1K | −0.1%1.10M after | |
| Oct 4, 2021 (view filing) | Sep 30-Oct 4 | 4 days | Schroeder ThiloDirector | SSale | −14.6K | $30.09 | −$439.8K | −1.3%1.10M after | 3 lots |
| Sep 29, 2021 (view filing) | Sep 27-29 | 2 days | Schroeder ThiloDirector | SSale | −7.46K | $30.06 | −$224.3K | −0.7%1.12M after | 2 lots |
| Sep 24, 2021 (view filing) | Sep 22 | 2 days | Schroeder ThiloDirector | SSale | −100 | $30.00 | −$3.00K | 0.0%1.12M after | |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Schroeder ThiloDirector | SSale | −711 | $30.03 | −$21.4K | −0.1%1.12M after | |
| Sep 13, 2021 (view filing) | Sep 9-13 | 4 days | Schroeder ThiloDirector | SSale | −70.8K | $30.41 | −$2.15M | −5.9%1.12M after | 4 lots |
| Sep 2, 2021 (view filing) | Aug 31-Sep 2 | 2 days | Schroeder ThiloDirector | SSale | −46.9K | $30.25 | −$1.42M | −3.8%1.20M after | 3 lots |
| Aug 30, 2021 (view filing) | Aug 26-30 | 4 days | Schroeder ThiloDirector | SSale | −58.8K | $30.45 | −$1.79M | −4.5%1.24M after | 5 lots |
| Aug 25, 2021 (view filing) | Aug 23-25 | 2 days | Schroeder ThiloDirector | SSale | −51.9K | $30.87 | −$1.60M | −3.2%1.59M after | 4 lots |
| Aug 20, 2021 (view filing) | Aug 18-19 | 2 days | Schroeder ThiloDirector | SSale | −30.7K | $33.05 | −$1.01M | −1.8%1.64M after | 4 lots |